Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Adamis Pharms Corp Drug Patent Portfolio

Adamis Pharms Corp owns 1 orange book drug protected by 1 US patent Given below is the list of Adamis Pharms Corp's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11141540 Syringe devices 20 Oct, 2036
Active


Given below is the list of recent legal activities going on the following drug patents of Adamis Pharms Corp.

Activity Date Patent Number
Patent litigations
Patent Issue Date Used in PTA Calculation
Critical
12 Oct, 2021 US11141540
Recordation of Patent Grant Mailed
Critical
12 Oct, 2021 US11141540
Email Notification
Critical
23 Sep, 2021 US11141540
Issue Notification Mailed
Critical
22 Sep, 2021 US11141540
Dispatch to FDC 14 Sep, 2021 US11141540
Application Is Considered Ready for Issue
Critical
14 Sep, 2021 US11141540
Issue Fee Payment Received
Critical
10 Sep, 2021 US11141540
Issue Fee Payment Verified
Critical
10 Sep, 2021 US11141540
Electronic Review
Critical
11 Jun, 2021 US11141540
Email Notification
Critical
11 Jun, 2021 US11141540
Mail Notice of Allowance
Critical
11 Jun, 2021 US11141540
Notice of Allowance Data Verification Completed
Critical
09 Jun, 2021 US11141540
Case Docketed to Examiner in GAU
Critical
12 May, 2021 US11141540
Case Docketed to Examiner in GAU
Critical
10 Nov, 2020 US11141540
Disposal for a RCE / CPA / R129 06 Nov, 2020 US11141540


Adamis Pharms Corp's Family Patents

Adamis Pharms Corp drugs have patent protection in a total of 17 countries. It's US patent count contributes only to 18.2% of its total global patent coverage. 1 country has all of their patents expired or invalidated which has opened up potential generic launch opportunities in this particular country. Click below to unlock the full patent family tree.

Family Patents



Adamis Pharms Corp Drug List

Given below is the complete list of Adamis Pharms Corp's drugs and the patents protecting them.


1. Symjepi

Symjepi is protected by 1 patent, which is still active. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11141540 Syringe devices 20 Oct, 2036
(11 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Symjepi's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List